Biblio

33557 resultats trouvés
Filtres: Filter is   [Clear All Filters]
C
Xiao N, Xie C, Jia E, Li J, Giust R, Courvoisier F, Hu M.  2021.  Caustic Interpretation of the Abruptly Autofocusing Vortex beams. OPTICS EXPRESS. 29:19975-19984.
Mathis A, Froehly L, Toenger S, Dias F, Genty G, Dudley JM.  2015.  Caustics and Rogue Waves in an Optical Sea. SCIENTIFIC REPORTS. 5:12822.
De Bari B.  2021.  Cautious SBRT. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 109:315.
Jeremies A, Lehmann U, Gruschinski S, Schleife F, Meyer M, Matulis V, Ivashkevich OA, Handke M, Stein K, Kersting B.  2015.  Cavitands Incorporating a Lewis Acid Dinickel Chelate Function as Receptors for Halide Anions. INORGANIC CHEMISTRY. 54:3937-3950.
Wang Y, Darut G, Poirier T, Stella J, Liao H, Planche M-pierre.  2017.  Cavitation erosion of plasma sprayed YSZ coatings produced by feedstocks with different initial sizes. TRIBOLOGY INTERNATIONAL. 111:226-233.
Wang Y, Liu J, Kang N, Darut G, Poirier T, Stella J, Liao H, Planche M-pierre.  2016.  Cavitation erosion of plasma-sprayed CoMoCrSi coatings. TRIBOLOGY INTERNATIONAL. 102:429-435.
Amiot C, Aalto A, Ryczkowski P, Toivonen J, Genty G.  2017.  Cavity enhanced absorption spectroscopy in the mid-infrared using a supercontinuum source. APPLIED PHYSICS LETTERS. 111:061103.
Cinar R, Park JK, Zawatsky CN, Coffey NJ, Bodine SP, Abdalla J, Yokoyama T, Jourdan T, Jay L, Zuo MXing G et al..  2021.  CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome. CLINICAL AND TRANSLATIONAL MEDICINE. 11:e471.
Gobeli M., Rigaud B., Charra-Brunaud C., Renard S., De Rauglaudre G., Beneyton V., Racadot S., Peignaux K., Leseur J., Williaume D. et al..  2018.  CBCT guided adaptive radiotherapy for cervix cancer: Uncertainty of the choice of the plan of the day. RADIOTHERAPY AND ONCOLOGY. 127:S606-S607.
Ben-Mabrouk H, Zouari-Kessentini R, Montassar F, Abdelkefi-Koubaa Z, Messaadi E, Guillonneau X, ElAyeb M, Srairi-Abid N, Luis J, Micheau O et al..  2016.  CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 86:670-680.
Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Genevieve F, Robillard N, Solly F, Maar A, Bene M-C, Mauvieux L.  2014.  CD180 Expression in B-Cell Lymphomas: A Multicenter Geil Study. BLOOD. 124
Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Genevieve F, Robillard N, Solly F, Maar A, Bene MC, Mauvieux L et al..  2016.  CD180 Expression in B-Cell Lymphomas: A Multicenter GEIL Study. CYTOMETRY PART B-CLINICAL CYTOMETRY. 90:462-466.
Mayeur-Rousse C, Guy J, Miguet L, Bouyer S, Genevieve F, Robillard N, Solly F, Maar A, Bene M-C, Mauvieux L.  2014.  CD180 Expression in B-Cell Lymphomas: A Multicenter Geil Study. BLOOD. 124
Paillassa J, Di Blasi R, Chevret S, Bernard S, Darmon M, Meignin V, Deau-Fischer B, Camus V, Casasnovas R-O, Cartron G et al..  2019.  CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria. BLOOD. 134
Vauchy C, Gamonet C, Ferrand C, Daguindau E, Galaine J, Beziaud L, Chauchet A, Dunand CJHenry, Deschamps M, Rohrlich PSimon et al..  2015.  CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes. INTERNATIONAL JOURNAL OF CANCER. 137:116-126.
Ghazavi F, Clappier E, Lammens T, Suciu S, Caye A, Zegrari S, Bakkus M, Grardel N, Benoit Y, Bertrand Y et al..  2015.  CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol. HAEMATOLOGICA. 100:1311-1319.
Bole-Richard E, Fredon M, Biichle S, Anna F, Certoux J-M, Renosi F, Tse F, Molimard C, Valmary-Degano S, Jenvrin A et al..  2020.  CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm. LEUKEMIA. 34:3228-3241.
Maffini E, Labopin M, Blaise D, Ciceri F, Gulbas Z, Daguindau E, Nguyen-Quoc S, Chevallier P, Socie G, Colorado M et al..  2019.  CD34+Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the Eu. BLOOD. 134
Sayed A., Sery O., Plesnik J., Daoudi H., Rouabah A., Rouabah L., Khan N.A.  2015.  CD36 AA genotype is associated with decreased lipid taste perception in young obese, but not lean, children. INTERNATIONAL JOURNAL OF OBESITY. 39:920-924.
Plesnik J., Mrizak I., Sery O., Arfa A., Fekih M., Bouslema A., Zaouali M., Tabka Z., Khan N.A.  2014.  CD36 AA single nucleotide polymorphism (SNP) is associated with decreased lipid taste perception in Tunisian obese women: association with pro-inflammatory TNF-a GA and IL-6 GC genotypes. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:7.
Plesnik J., Mrizak I., Sery O., Arfa A., Fekih M., Bouslema A., Zaouali M., Tabka Z., Khan N.A.  2014.  CD36 AA single nucleotide polymorphism (SNP) is associated with decreased lipid taste perception in Tunisian obese women: association with pro-inflammatory TNF-a GA and IL-6 GC genotypes. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:7.
Subramaniam S., Ozdener M.H, Sundaresan S., Sery O., Besnard P., Abumrad N.A, Khan N.A.  2014.  CD36 and GPR120 differently mediate Ca2+ signaling in human taste bud cells. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:87.
Subramaniam S., Ozdener M.H, Sundaresan S., Sery O., Besnard P., Abumrad N.A, Khan N.A.  2014.  CD36 and GPR120 differently mediate Ca2+ signaling in human taste bud cells. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:87.
Berrichi M, Hichami A, Addou-Klouche L, Khan ASayed, Khan NAkhtar.  2020.  CD36 and GPR120 Methylation Associates with Orosensory Detection Thresholds for Fat and Bitter in Algerian Young Obese Children. JOURNAL OF CLINICAL MEDICINE. 9:1956.
Matuskova V, Balcar VJ, Khan NA, Bonczek O, Ewerlingova L, Zeman T, Kolar P, Vyslouzilova D, Vlkova E, Sery O.  2018.  CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy. OPHTHALMIC GENETICS. 39:4-10.

Pages